Research Reports

Healthcare

icon
Home » Reports » Global Diabetic Footwear Shoes Market Analysis Opportunity Outlook 2021
Market Research Report

Global Diabetic Footwear (Shoes) Market Analysis & Opportunity Outlook 2021

Published On : 09:40 AM, 14th September, 2017 REP-ID-51 Category: Healthcare

Diabetes is a prolonged medical condition, which is caused by low levels of insulin in the body. A person suffering from diabetes is more prone to develop wounds, ulcers or lack of sensation in any part of his body, particularly in his feet. Diabetic/therapeutic shoes have evolved as a medical revolution as it aids in preventing the feet of a diabetic person from developing any injuries or wounds with the help of its unique design and therapeutic properties.

The global market of diabetic footwear (shoes) is anticipated to flourish at a healthy compound annual growth rate (CAGR) of 8.27% during the forecast period i.e. 2015-2021. The global diabetic (therapeutic footwear, orthopedic shoes) market would majorly be driven by the rising prevalence of diabetes (in 20-79 years of age group) in the world.

Diabetic footwear (Shoes)                        

Apart from rising prevalence of diabetes, rise in spending on diabetes treatment is yet another major growth driver of the diabetic footwear (shoes) market. The global spending on diabetes is projected to expand from USD 936 Billion in 2015 to USD 1,128 Billion by 2021. This rise in spending would definitely help the global diabetic footwear market in the coming 8-10 years of time. 

Regionally, Asia Pacific region is anticipated to witness the highest growth in the diabetic footwear (shoes) market, with China being the largest market in the region followed by India during the forecast period i.e. 2015-2021. Growth in the aging population, strengthening economic condition, better GDP figures and increase in the per capita income are some of the major factors that would escalate the demand of diabetic footwear in the Asia Pacific region.

The global diabetic footwear or othopedic shoes or therapeutic shoes market is segmented on the basis of demography, which depicts that women have higher tendency to purchase the diabetic footwear (shoes) than men. Owing to this tendency, the female diabetic footwear (68% share in 2014), occupies the largest market of diabetic footwear across the globe. However, owing to an increase in the total number of male diabetic patients in comparison to female diabetic patients in the world, there is a greater need of male diabetic footwear in the future.

In addition to demography, the orthopedic shoes market is also segmented by inpatients and outpatients and by retail distribution. The retail distribution is further segmented into on-line and off-line retail out of which, the on-line distribution channel with 71% share is anticipated to have the largest share by 2021. The major reason behind the growth of e-commerce channels can be attributed to rising penetration of smartphones and high speed internet services like 3G and 4G in the world. 

In contrast, lack of awareness regarding proper feet care in diabetic patients and lack of knowledge in terms of use of diabetic footwear  (orthopedic shoes) is one of the major obstacles that hinder the growth of the diabetic footwear market across the globe.

DARCO International, Ortho Europe, Duna Srl, Thuasne, DJ Global, Hong Kong Grace Shoes, Dr. Zen Inc., Drew Shoe Corporation, and Podartis Srl are some of the major key players of the global diabetic footwear (orthopedic shoes) market.

 

                Key Answers Captured in Report?

Which geography would have better demand for product/services?
What are the strategies adopted by big players in the regional market?
Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth?
What is the current & expected market size in next five years?
What is the market feasibility for long term investment?
What opportunity the country would offer for existing and new players in the market?
What is risk involved for suppliers in the geography?
What factors would drive the demand for the product/service in near future?
What is the impact analysis of various factors in the market growth?
What are the recent trends in the regional market and how successful they are?

1. List of Figures
2. List of Tables 
3. Executive Summary 
4. Research Methodology 
5. Global Diabetic Footwear Market Size and Forecast 
6. Market Segmentation
6.1 By Regions
6.1.1 North America Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.1.1 U.S. Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.1.2 Canada Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.1.3 Mexico Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.1.4 Market Attractiveness of North America
6.1.1.5 BPS Analysis of North America
6.1.2 Europe Market Size ($ Milion) & Y-O-Y Growth Analysis, 2015-2021
6.1.2.1 U.K. Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.2 Germany Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.3 France Market Size ($ Milion) & Y-O-Y Growth Analysis, 2015-2021
6.1.2.4 Spain Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.5 Italy Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.6 Hungary Market Size ($  Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.7 Benelux (Belgium, Netherlands and Luxembourg) Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.8 Market Attractiveness of Europe
6.1.2.9 BPS Analysis of Europe
6.1.3 Russia Market Size ($) & Y-O-Y Growth Analysis, 2015-2021
6.1.4 Asia Pacific Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.1 India Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.2 China Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.3 Singapore Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.4 Japan Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.5 Market Attractiveness of Asia-Pacific
6.1.4.6 BPS Analysis of Asia Pacific
6.1.5 MENA Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.6 Latin America Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.7 Oceanic Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.7.1 Australia Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.7.2 New Zealand Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.7.3 Market Attractiveness of Oceanic region
6.1.7.4 BPS Analysis of Oceanic Region
6.2 By Demography
6.3 By Inpatient and Outpatient
6.4 By Retail Distribution 

7. Porter’s Five Force Model Analysis 

8. Industry Growth Drivers
8.1 Rise in prevalence of diabetes in the world
8.1.1 Impact Analysis
8.2 Growth in the aging population
8.2.1 Impact Analysis
8.3 Increasing demand of customized diabetic footwear
8.3.1 Impact Analysis
8.4 Rise in spending on diabetes treatment
8.4.1 Impact Analysis

9. Restraints
9.1 High cost of diabetic footwear
9.1.1 Impact Analysis
9.2 Lack of awareness
9.2.1 Impact Analysis

10. Risk Analysis
10.1 Supply Risk -Medium
10.2 Demand Risk -Medium

11. Competitive Landscape
11.1 DARCO International Inc.
11.1.1 Company Overview
11.1.2 Products and Services
11.1.3 Key Financials
11.1.4 Recent News and Developments
11.2 Sigvaris
11.2.1 Company Overview
11.2.2 Products and services
11.2.3 Key Financials
11.2.4 Recent News and Developments
11.3 Ortho Europe
11.3.1 Company Overview
11.3.2 Products and Services
11.3.3 Key Financials
11.3.4 Recent news and developments
11.4 Duna Srl
11.4.1 Company Overview
11.4.2 Products and services
11.4.3 Key Financials
11.4.4 Recent News & Developments
11.5 Thuasne
11.5.1 Company Overview
11.5.2 Products and Services
11.5.3 Key Financials
11.5.4 Recent news & developments
11.6 Medline Industries
11.6.1 Company Overview
11.6.2 Products and services
11.6.3 Key Financials
11.6.4 Recent news & Developments
11.7 DJ Global Inc.
11.7.1 Company Overview
11.7.2 Products and services
11.7.3 Key Financials
11.7.4 Recent news & developments
11.8 Hong Kong Grace Shoes Development Co Ltd.
11.8.1 Company Overview
11.8.2 Products and services
11.8.3 Key Financials
11.8.4 Recent news & developments
11.9 Dr. Zen Inc.
11.9.1 Company Overview
11.9.2 Products and services
11.9.3 Key Financials
11.9.4 Recent news & developments
11.10 Supad
11.10.1 Company Overview
11.10.2 Products and services
11.10.3 Key Financials
11.10.4 Recent news & developments
11.11 Drew Shoe Corporation USA
11.11.1 Company Overview
11.11.2 Products and Services
11.11.3 Key Financials
11.11.4 Recent news & Developments
11.12 Podartis Srl
11.12.1 Company Overview
11.12.2 Products and Services
11.12.3 Key Financials
11.12.4 Recent news & developments
11.13 Aetrex Worldwide, Inc.
11.13.1 Company overview
11.13.2 Products and Services
11.13.3 Key Financials
11.13.4 Recent news & developments 

List of Figures:
Figure 5-1: Global Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 5-2: Total number of diabetic patients (age 20-79 years) in the world
Figure 6-1: The U.S. Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-2: Number of diabetic population (in millions) in the U.S., 2010-2014
Figure 6-3: Major causes of amputations in U.S.
Figure 6-4: Canada Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-5: Total number of diabetic patients in Canada (age > 12)
Figure 6-6: Total health expenditure (USD Millions) in Canada during 2010-2014
Figure 6-7: Mexico Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-8: Total number of diabetic patients in Mexico (age 20-79 years), 2014-2021
Figure 6-9: North America Market Attractiveness
Figure 6-10: North America BPS Analysis
Figure 6-11: U.K. Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-12: Germany Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-13: Diabetes prevalence % in Germany (age 20-79) years during 2013-2035
Figure 6-14: France Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-15: Total number of diabetic patients (age-20-79 years) in France 2013-2030
Figure 6-16: Spain Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-17: % of people (having diabetes type 2) suffering from other diseases in Spain
Figure 6-18: Italy Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-19: Total number of diabetic patients (in millions) in Italy (age 20-79 years)
Figure 6-20: % distribution of budget on diabetes by Italy
Figure 6-21: Hungary Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-22: Belgium Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-23: Netherlands Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-24: Luxembourg Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-25: Europe Market Attractiveness
Figure 6-26: Europe BPS Analysis
Figure 6-27: Russia Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-28: Total number of diabetic patients (age 20-79 years) in Russia, 2013-2021
Figure 6-29: India Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-30: Total number of diabetic patients (in millions) in India (age 20-79 years), 2007-2030
Figure 6-31: % of types of foot ulcers in India
Figure 6-32: China Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-33: Total number of diabetic patients (in millions) in China (age 20-79 years), 2013-2035
Figure 6-34: Singapore Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-35: Japan Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-36: Total number of diabetic population (age 20-79 years) in Japan, 2011-2014
Figure 6-37: % share of population according to age group in Japan
Figure 6-38: Asia-Pacific Market Attractiveness
Figure 6-39: Asia-Pacific BPS Analysis
Figure 6-40: MENA Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-41: Diabetes prevalence rates by country in MENA, 2014
Figure 6-42: Latin America Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-43: Australia Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-44: Australia Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-45: Real gross national disposable income per person (USD ‘000’) in New Zealand,
Figure 6-46: Oceanic Region Market Attractiveness
Figure 6-47: Oceanic Region BPS Analysis
Figure 6-48: % market share by demography in 2014
Figure 6-49: % market share by demography in 2021
Figure 6-50: % of male and female diabetic population in the U.S.
Figure 6-51: % of male and female diabetic population in Canada
Figure 6-52: % of male and female diabetic population in Europe (age>25)
Figure 6-53: % of male and female diabetic population in the United Kingdom
Figure 6-54: % of male and female diabetic population in India
Figure 6-55: % of adult male and female diabetic population in China
Figure 6-56: % market share by inpatient and outpatient in 2014
Figure 6-57: % market share by inpatient and outpatient in 2021
Figure 6-58: Annual health spending (per capita) % growth in Germany
Figure 6-59: % market share by retail distribution in 2014
Figure 6-60: % market share by retail distribution in 2021
Figure 6-61: % market share by medical specialty and street stores in 2014
Figure 6-62: % market share by medical specialty and street stores in 2021
Figure 6-63: Sales of online stores in the U.S. from 2014-2016E (USD Billions)
Figure 6-64: Sales of departmental stores in the U.S. (USD Billions) during 2011-2015
Figure 6-65: % share of online retail outlets in Europe by country in 2015
Figure 6-66: E-commerce % share of total retail sales, India and China (2013-2017)
Figure 6-67: E-commerce market size of U.A.E., Saudi Arabia and Egypt forecast to 2020
Figure 6-68: E-commerce market size in Brazil, Argentina and Mexico, forecast to 2019
Figure 7-1: Porter`s Five Force Model, 2016 

List of Tables:
Table 5-1: Ranking of countries in terms of adult (age 20-79 years) diabetic population (in millions) in 2015 and 2040
Table 5-2: Ranking of countries in terms of diabetes related health expenditure (USD Billions) in 2015 and 2040
Table 6-1: Diabetes prevalence % in major countries of U.K. (2012-13)
Table 11-1: DJO Global key financials (USD Millions), 2012-2014
Table 11-2: DJO Global net sales by products (USD Millions), 2012-2014
Table 11-3: DJO Global net sales by country (USD Millions), 2012-2014
Table 6-1: Diabetes prevalence % in major countries of U.K. (2012-13)
Table 11-1: DJO Global key financials (USD Millions), 2012-2014
Table 11-2: DJO Global net sales by products (USD Millions), 2012-2014
Table 11-3: DJO Global net sales by country (USD Millions), 2012-2014

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

1014, 10th Floor, Tower A1,
Ansal Corporate Park, Plot no 7A/1,
Sector 142 Noida., 201301 India
Phone : +91 958 228 3827, +91 120 660 5495
info@researchnester.com

US Office

1820 Avenue M, Suite# 1113,
Brooklyn, New York 11230
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2017 Research Nester. All rights reserved

Top